APA

Tong G., Wang J., Sverdlov O., Huang S., Slemmon R., Croop R., Castaneda L., Gu H., Wong O., Li H., Berman R. M., Smith C., Albright C. F. & Dockens R. (20130805). A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat. : British journal of clinical pharmacology.

Chicago

Tong Gary, Wang Jun-Sheng, Sverdlov Oleksandr, Huang Shu-Pang, Slemmon Randy, Croop Robert, Castaneda Lorna, Gu Huidong, Wong Oi, Li Hewei, Berman Robert M, Smith Christina, Albright Charles F and Dockens Randy. 20130805. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat. : British journal of clinical pharmacology.

Harvard

Tong G., Wang J., Sverdlov O., Huang S., Slemmon R., Croop R., Castaneda L., Gu H., Wong O., Li H., Berman R. M., Smith C., Albright C. F. and Dockens R. (20130805). A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat. : British journal of clinical pharmacology.

MLA

Tong Gary, Wang Jun-Sheng, Sverdlov Oleksandr, Huang Shu-Pang, Slemmon Randy, Croop Robert, Castaneda Lorna, Gu Huidong, Wong Oi, Li Hewei, Berman Robert M, Smith Christina, Albright Charles F and Dockens Randy. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat. : British journal of clinical pharmacology. 20130805.